Sciety

Open Science Discovery of Potent Non-Covalent SARS-CoV-2 Main Protease Inhibitors

This article has 12 authors:
1. Melissa L. Boby
2. Daren Fearon
3. Matteo Ferla
4. Mihajlo Filep
5. Lizbé Koekemoer
6. Matthew C. Robinson
7. The COVID Moonshot Consortium
8. John D. Chodera
9. Alpha A Lee
10. Nir London
11. Annette von Delft
12. Frank von Delft
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Sep 6, 2023Latest activity Nov 2, 2020
ACE2 peptide fragment interacts with several sites on the SARS-CoV-2 spike protein S1

This article has 7 authors:
1. Aleksei Kuznetsov
2. Piret Arukuusk
3. Heleri Härk
4. Erkki Juronen
5. Ülo Langel
6. Mart Ustav
7. Jaak Järv
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Dec 29, 2020Latest activity Dec 30, 2020
An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor

This article has 17 authors:
1. Daniel Zaidman
2. Paul Gehrtz
3. Mihajlo Filep
4. Daren Fearon
5. Ronen Gabizon
6. Alice Douangamath
7. Jaime Prilusky
8. Shirly Duberstein
9. Galit Cohen
10. C. David Owen
11. Efrat Resnick
12. Claire Strain-Damerell
13. Petra Lukacik
14. Haim Barr
15. Martin A. Walsh
16. Frank von Delft
17. Nir London
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Dec 1, 2021Latest activity Sep 28, 2020
Fluorescent Glycan Fingerprinting of SARS2 Spike Proteins

This article has 2 authors:
1. Zhengliang L Wu
2. James M Ertelt
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 18, 2021Latest activity Jan 19, 2021
No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor

This article has 5 authors:
1. Jarrod Shilts
2. Thomas W. M. Crozier
3. Edward J. D. Greenwood
4. Paul J. Lehner
5. Gavin J. Wright
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 11, 2021Latest activity Jul 27, 2020
Structural characterization of cocktail-like targeting polysaccharides from Ecklonia kurome Okam and their anti-SARS-CoV-2 activities invitro

This article has 16 authors:
1. Shihai Zhang
2. Rongjuan Pei
3. Meixia Li
4. Hao Sun
5. Minbo Su
6. Yaqi Ding
7. Xia Chen
8. Zhenyun Du
9. Can Jin
10. Chunfan Huang
11. Yi Zang
12. Jia Li
13. Yechun Xu
14. Xinwen Chen
15. Bo Zhang
16. Kan Ding
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 15, 2021Latest activity Jan 16, 2021
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations

This article has 22 authors:
1. Michael Westberg
2. Yichi Su
3. Xinzhi Zou
4. Pinghan Huang
5. Arjun Rustagi
6. Jaishree Garhyan
7. Puja Bhavesh Patel
8. Daniel Fernandez
9. Yan Wu
10. Chenzhou Hao
11. Chieh-Wen Lo
12. Marwah Karim
13. Lin Ning
14. Aimee Beck
15. Panatda Saenkham-Huntsinger
16. Vivian Tat
17. Aleksandra Drelich
18. Bi-Hung Peng
19. Shirit Einav
20. Chien-Te K. Tseng
21. Catherine Blish
22. Michael Z. Lin
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Mar 13, 2024Latest activity Sep 21, 2020
Effect of β-chitosan on the binding interaction between SARS-CoV-2 S-RBD and ACE2

This article has 15 authors:
1. Gulimiran Alitongbieke
2. Xiu-min Li
3. Qi-Ci Wu
4. Zhi-Chao Lin
5. Jia-Fu Huang
6. Yu Xue
7. Jing-Na Liu
8. Jin-Mei Lin
9. Tao Pan
10. Yi-Xuan Chen
11. Yi Su
12. Guo-Guang Zhang
13. Bo Leng
14. Shu-Wen Liu
15. Yu-Tian Pan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Sep 18, 2020Latest activity Aug 2, 2020
Cryo-EM Structures of the SARS-CoV-2 Endoribonuclease Nsp15

This article has 16 authors:
1. Monica C. Pillon
2. Meredith N. Frazier
3. Lucas B. Dillard
4. Jason G. Williams
5. Seda Kocaman
6. Juno M. Krahn
7. Lalith Perera
8. Cassandra K. Hayne
9. Jacob Gordon
10. Zachary D. Stewart
11. Mack Sobhany
12. Leesa J. Deterding
13. Allen L. Hsu
14. Venkata P. Dandey
15. Mario J. Borgnia
16. Robin E. Stanley
Reviewed by ScreenIT

This article has 2 evaluationsAppears in 1 listLatest version Aug 11, 2020Latest activity Aug 14, 2020
An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants

This article has 4 authors:
1. Kui K. Chan
2. Timothy J. C. Tan
3. Krishna K. Narayanan
4. Erik Procko
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Feb 19, 2021Latest activity Oct 22, 2020

Previous Page 64 of 82 Next

Biochemistry

Open Science Discovery of Potent Non-Covalent SARS-CoV-2 Main Protease Inhibitors

ACE2 peptide fragment interacts with several sites on the SARS-CoV-2 spike protein S1

An automatic pipeline for the design of irreversible derivatives identifies a potent SARS-CoV-2 Mpro inhibitor

Fluorescent Glycan Fingerprinting of SARS2 Spike Proteins

No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor

Structural characterization of cocktail-like targeting polysaccharides from Ecklonia kurome Okam and their anti-SARS-CoV-2 activities invitro

An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations

Effect of β-chitosan on the binding interaction between SARS-CoV-2 S-RBD and ACE2

Cryo-EM Structures of the SARS-CoV-2 Endoribonuclease Nsp15

An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants